A diversiﬁed portfolio of actively managed high-growth companies seeking commercialisation funding, the Deepbridge EIS invests in technology growth companies that have a proven technology, clear intellectual property and are operating in a high growth/highvalue market sector.
The investment strategy of the Deepbridge Life Sciences EIS is to invest in a diversiﬁed portfolio of investee companies that develops a highly disruptive proposition in one of the following sectors; biopharmaceuticals, biotechnology or medical technology.
The Deepbridge Life Sciences SEIS seeks to fund companies with exciting new innovations that satisfy the needs of the rapidly growing life sciences market.
The Deepbridge Innovation SEIS invests in a portfolio of investee companies that are developing innovations within the digital and technology sectors.
Telephone: 01244 746000
For more information go to www.deepbridgecapital.com